The document discusses EU and national funding opportunities for public health research. It outlines that UK organizations can continue applying to Horizon 2020 funding while the UK remains in the EU. The EU Public Health Programme aims to improve health policies and protect citizens from health threats. It provides grants and joint actions for members states on topics like chronic diseases, tobacco control, and antimicrobial resistance. Horizon 2020 also has funding calls in health and demographic change on areas like rare diseases, regenerative medicine, and economic evaluation in health. National funding in Ireland is also outlined from the Health Research Board.
The PPT describes about the healthcare issues in Europe and how eHealth is becoming a solution for those issues. Also the policy for eHealth in Europe. For more information visit: http://www.transformhealth-it.org/
Food Nutrition Health RI presented at IAAE VancouverKrijn Poppe
Presentation of the Food Nutrition and Health Research Infrastructure, as developed in European projects EuroDISH and Richfields, for the IAAE Conference 2018 in Vancouver
Workshop 7 - Brainstorming & Policy Development session: Prevention
"EUROCAT Study on Prevention of Congenital Anomalies"
Dr. Domenica Taruscio, ISS Italy
The PPT describes about the healthcare issues in Europe and how eHealth is becoming a solution for those issues. Also the policy for eHealth in Europe. For more information visit: http://www.transformhealth-it.org/
Food Nutrition Health RI presented at IAAE VancouverKrijn Poppe
Presentation of the Food Nutrition and Health Research Infrastructure, as developed in European projects EuroDISH and Richfields, for the IAAE Conference 2018 in Vancouver
Workshop 7 - Brainstorming & Policy Development session: Prevention
"EUROCAT Study on Prevention of Congenital Anomalies"
Dr. Domenica Taruscio, ISS Italy
Public-Private Partnerships (PPPs) as an Instrument to Achieve Sustainable Development Goals (SDGs) in healthcare. SDG Agenda sets new benchmark for infrastructure projects. A presention made for 3rd PPP Forum in China ( Bejing, 1 December 2018)
Work Package (WP) 12 – PEARL Barriers In search for an inventory and assessme...ExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
International challenges regarding the future sharing of sequence data. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Community Nursing Research Strategy Masterclass
13th September 2013
The WSPCR was requested to organise a research masterclass for the Directors of Nursing from all the Welsh Health Boards on Friday 11th Sept. It was funded by the Health Minister and attended by the CNO. It also included the Head of the NISCHR and the manager of AHSC. The masterclass included the presentation of the Welsh Community Nurse Research Strategy which aims to raise the quality and quantity of research in Community Nursing in Wales. The workshop also generated further areas for research activity/priority.
http://www.wspcr.ac.uk/crns-masterclass-sep-2013.php
Mr. Mika Salminen, SHARP JA Coordinator, Director, Department of Health Security, Finnish Institute for Health and Welfare (THL), at One Health Security Conference, 14-15 Oct 2019, THL, Helsinki
US University Research Funding, Peer Reviews, and MetricsDaniel S. Katz
My part of the "Digital Science Webinar: Articulating Research Impact – Strategies from Around the Globe" (http://www.digital-science.com/events/digital-science-webinar-articulating-research-impact-strategies-from-around-the-globe/)
Daniel S. Katz will discuss how reviewers at the National Science Foundation (USA) consider the “intellectual merit” and “broader impacts” criteria for funding and in particular how metrics might help applicants understand their impacts in these areas.Dan will also talk about how reviewers might use qualitative and quantitative altmetrics data to inform their peer reviews for grant applications. He will address many of the salient questions around this use of metrics, for example, do reviewers take metrics seriously and what types of metrics are of most value to them?
Public-Private Partnerships (PPPs) as an Instrument to Achieve Sustainable Development Goals (SDGs) in healthcare. SDG Agenda sets new benchmark for infrastructure projects. A presention made for 3rd PPP Forum in China ( Bejing, 1 December 2018)
Work Package (WP) 12 – PEARL Barriers In search for an inventory and assessme...ExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
International challenges regarding the future sharing of sequence data. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
Community Nursing Research Strategy Masterclass
13th September 2013
The WSPCR was requested to organise a research masterclass for the Directors of Nursing from all the Welsh Health Boards on Friday 11th Sept. It was funded by the Health Minister and attended by the CNO. It also included the Head of the NISCHR and the manager of AHSC. The masterclass included the presentation of the Welsh Community Nurse Research Strategy which aims to raise the quality and quantity of research in Community Nursing in Wales. The workshop also generated further areas for research activity/priority.
http://www.wspcr.ac.uk/crns-masterclass-sep-2013.php
Mr. Mika Salminen, SHARP JA Coordinator, Director, Department of Health Security, Finnish Institute for Health and Welfare (THL), at One Health Security Conference, 14-15 Oct 2019, THL, Helsinki
US University Research Funding, Peer Reviews, and MetricsDaniel S. Katz
My part of the "Digital Science Webinar: Articulating Research Impact – Strategies from Around the Globe" (http://www.digital-science.com/events/digital-science-webinar-articulating-research-impact-strategies-from-around-the-globe/)
Daniel S. Katz will discuss how reviewers at the National Science Foundation (USA) consider the “intellectual merit” and “broader impacts” criteria for funding and in particular how metrics might help applicants understand their impacts in these areas.Dan will also talk about how reviewers might use qualitative and quantitative altmetrics data to inform their peer reviews for grant applications. He will address many of the salient questions around this use of metrics, for example, do reviewers take metrics seriously and what types of metrics are of most value to them?
Fundraising Crash Course by Jeanne Minnicks surveys the strategies, goals, and relationships necessary for a successful development department.
For a Follow Up Whitepaper, Visit:
http://go.donorpro.com/5-modern-fundraising-strategies-nuture-prospects
In today’s economic climate, there is more pressure than ever to ensure a steady stream of fundraising revenue and increase fundraising results with limited resources. To meet that challenge one must analyze current fundraising activities and develop an effective annual development plan to capitalize on strengths and improve areas of weakness. At the October 20, 2011 AFP Northeast Indiana luncheon, fundraising consultant Robert Croft, CFRE presented this program to show you how to conduct a self guided development audit to evaluate your current fundraising efforts, which donor metrics are most critical to track for growth, and how to create a plan that is unique to your organization that will improve your fundraising results.
Best practices to fund, develop and commercialize evidence-based innovationSharpBrains
In this session we discussed key lessons learned for scientists and start-ups to successfully bring to market evidence-based innovative solutions. We will also present non-dilutive funding opportunities and commercialization resources offered through the US small business research programs. A scientist and inventor turned serial entrepreneur will wrap-up the day sharing insights from his previous venture–funded by the NIMH and sold to McKesson–and his current strategy and vision.
--Chair: Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization
--Dr. Margaret Grabb, SBIR/STTR Program Director at the National Institute of Mental Health (NIMH)
--Dr. Rex Jakobovits, Founder of Vivalog Technologies and Experiad
Learn more at sharpbrains.com
6 Easy Steps to Creating a Written Fundraising PlanAbila
Many nonprofits struggle to create a fundraising plan and put it in writing, yet the benefits are tremendous. A written plan shifts you from being reactive and dealing with the crisis of the day to being proactive and working purposefully toward the results you want. In this session, you’ll learn how to follow 6 simple steps to put together a written plan for raising the money you need in the coming year.
The European, Chinese, and United States healthcare markets are a study of contrasts, each of which face a unique set of challenges and issues for their combined 2.4 billion citizens. Despite their differences, there are a number of opportunities for organizations to learn and profit through intercontinental collaboration on their paths to a more connected healthcare ecosystem. Panelists representing the three regions will provide an overview of their country’s unique healthcare landscape and offer a vision for a future of collaboration and progress.
• Brian O'Connor - Chair, European Connected Health Alliance
• Millard Chiang - Chairman, China Connected Health Alliance; Chair, Pegasus Holdings Group
• Julien Venne - Strategic Advisor & European Project Team Leader, European Connected Health Alliance
• David Whitlinger - Executive Director, New York eHealth Collaborative
New York eHealth Collaborative Digital Health Conference
November 18, 2014
Presentation by Jo Ward, North West Social Prescribing Network Co-Chair: Social Prescribing Network and creative health agenda at the Health, wellbeing and the environment event on Monday 28 January 2019 at The Isla Gladstone Conservatory, Liverpool
Horizon 2020 Calls on Infectious Diseases and Improving Global HealthKTN
The webinar provided background information on various call topics and on support available for both UK and European organisations in how to apply for funding and search for partners. KTN hosted this event on behalf of Innovate UK and was delivered by Samana Brannigan, National Contact Point for Health, and Stephen Alexander, National Contact Point for Legal and Financial Issues.
The webinar gave an overview of H2020 Health Call topics, and support available for UK organisations in how to apply for funding, as well as information on Brexit and the continuation of UK participation in H2020. This enabled attendees to gain an insight into the benefits of participating, guidelines for preparing a project outline and the support and collaboration tools available.
In summary, the webinar covered:
- Open and Forthcoming Health Call Topics
- Support for UK Organisations
- UK participation in Horizon 2020
Find out more about the Health Special Interest Group at https://ktn-uk.co.uk/interests/health
John F Ryan, Director, European Commission presenting at the EPA/HSE Environment & Health Conference, Dublin on the European Environment and Health Priorities
Current regulations regarding eHealth in Europe by Frank Lievens, Executive Secretariat ISfTeH Director, Managing Director Lievens-Lanckman bvba, Belgium
Dr Liz Mear, Chief Executive of the Innovation Agency presented at NHS Confed 17 about the NHS’ role in growing local economies and how Academic Health and Science Networks (AHSNs) can generate economic growth in life sciences through their role as catalysts, connectors and collaborators by spreading innovation, advancing health technology and improving healthcare
Similar to Kay Duggan-Walls - Funding Opportunity for Public Health Research/Practice (20)
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
Kay Duggan-Walls - Funding Opportunity for Public Health Research/Practice
1. EU & National Funding for
Public Health Research
Kay Duggan-Walls
National Contact Point, Horizon 2020 Health
National Focal Point, Public Health Programme
IPH Conference Belfast
11 October 2016
2. Brexit & EU funding
• The UK Government and the European Commission confirmed earlier in the
summer that the UK EU referendum result had no immediate effect on UK
organisations applying to or participating in Horizon 2020 and that they could
continue to apply to the programme in the usual way.
• Statement from Jo Johnson, MP:
https://www.gov.uk/government/news/statement-on-higher-education-and-res...
Statement from European Commission:
https://ec.europa.eu/programmes/horizon2020/en/news/outcome-referendum-
u...
• In addition to these statements, we are pleased to inform you that the HM
Treasury (the UK finance ministry) guaranteed that all UK organisations bidding
individually or as members of consortia for Horizon 2020 projects, while the UK is
still a member of the EU, will have certainty over future funding with the Treasury
underwriting the payments of such awards, even when specific projects continue
beyond the UK’s departure from the EU.
• Statement from Chancellor Philip Hammond:
https://www.gov.uk/government/news/chancellor-philip-hammond-guarantees-...
3. EU Public Health Programme
• Health programme is about fostering health in Europe by
encouraging cooperation between member states to improve
the health policies that benefit their citizens
• Aims to support and complement MS health initiatives
Objectives
I. Promote health & prevent diseases, foster supportive environments
for healthy lifestyles
II. Protect Citizens from serious cross-border health threats
III. Contribute to innovative, efficient and sustainable health systems
IV. Facilitate access to better and safer healthcare for EU citizens
4. EU Public Health Programme
Project Grants
• Call open Spring 2017 - Deadline approx. 2-3 months
• http://ec.europa.eu/research/participants/portal/desktop/en/oppo
rtunities/3hp/calls/hp-pj-2016.html#c,topics=callIdentifier/t/HP-PJ-
2016
• Eligibility: 3 different partners from 3 different EU countries
• < 3 years duration
• Co-funding 60% eligible costs covered by EU contribution
• Migrants health, chronic diseases, smoking, alcohol (underage
drinking), donation of blood, tissues and cells, frailty, healthcare
associated infection, early diagnosis TB and hepatitis
• Recently funded project – HepCare Europe Hepatitis C – Jack
Lambert, Mater Hospital, Walter Cullen, UCD, HSE - €1.7 million
5. EU Public Health Programme
• Joint Actions
Co-financed by competent authorities responsible for health in member
states (DOH). Public sector bodies and non-governmental bodies mandated
by DOH can also participate.
2016
• Quality of HIV/AIDS/STI, viral Hepatitis and tuberculosis prevention and
linkage to care (€ 2 000 000 EU co-funding)
• JA-02-2016 - Action on chronic diseases (€ 5 000 000 EU co-funding)
• JA-03-2016 - Tobacco control (€ 2 000 000 EU co-funding)
• JA-04-2016 - Antimicrobial resistance and Health Care Associated
Infections(€ 4 000 000 EU co-funding)
• JA-05-2016 - Authorisation of preparation processes in blood and tissues
and cells (€ 800 000 EU co-funding)
6. EU Health Policy Platform
• New way of communicating between
Commission services and health stakeholders &
amongst stakeholders
• https://webgate.ec.europa.eu/hpf/
• Platform – Stakeholders discuss public health
issues, jointly produce statements on subjects,
share knowledge, promote events, exchange
documents
• Regular meetings – twice/year face-to-face
meetings
7. Horizon 2020
Horizon 2020 is the biggest EU Research and Innovation programme ever
€80 billion of funding available over 7 years (2014 to 2020)
It promises more breakthroughs, discoveries and world-firsts by taking great ideas
from the lab to the market.
8. Horizon 2020 - Health Demographic
Change and well being
• 2017 call –
SC-PM-03-2017 Diagnostic characterisation of rare diseases €15 M (budget €15 M),
closing date: 11 Apr 2017, single-stage -
SC-PM-11-2016-2017 Clinical research on regenerative medicine €4-6 M (budget
€30M), closing date: 11th April 2017, Single-stage
SC-PM-15-2017 Personalised coaching for well-being of people as they age €3-4 M
(budget €25 M), closing date: 31 Jan 2017, Single-stage
SC-PM-16-2017 In-silico trials for developing and assessing biomedical products€4-6M,
(budget €19M), Closing date: 14 Mar 2017, Single-stage
SC- PM-17-2017 Personalised computer models and in-silico systems for well-being
€4-6 M (budget €19 M), closing date: 14 Mar 2017, Single-stage
SC-PM-19-2017 PPI for uptake of standards for the exchange of digitalised healthcare
records €3-4 M (35% eligible costs)(budget €8.26 M), closing date: 14 Mar 2017,
Single-stage
SC-PM-20-2017 Development of new methods and measures for improved economic
evaluation and efficiency measures in the health sector (budget €9M), closing date: 11
Apr 2017, Single-stage
9. Health Work Programme 2016/2017
• Topics are Multidisciplinary
• Opportunities for dissemination, communication and
training activities
• Public engagement
• Work life, lifestyle aspects
• Patient involvement (caregivers also)
• Leisure, social participation
• User needs
• Ethics Issues
• Gender Issues
10. • Clinical, public health & socio-economic research, deployment of policy strategies, new
technologies (e.g. ICT, social platforms, new types data geographical, genetic, eHealth
records etc.
• Engage with international, national, regional authorities – ensure finding translated
into policy
• Public engagement, dissemination, communication, training, policy, lifestyle
management, environmental, occupational, epidemiological surveys, capacity building,
best practice
• Involve patients & take their views into account wherever relevant
• Non-pharmacological therapies
• User acceptance of ICT based technologies, training of professionals, domestic
rehabilitation (physical & cognitive), communication, patient consent
• Multidisciplinary research including behavioural, sociological, health
• Solutions should be: cost-effective, acceptable to end-users, applicable to realistic
settings, driven by needs, interests & lifestyles of older people, reduction of isolation &
loneliness, adaptation towards different histories & cultures across the EU
• Legal, ethical & social issues to be considered
• Its stated impact should be broad, addressing economic and social benefits & its effect
on reducing inequalities. Proposals should be multidisciplinary
11. Birth Day Prize
Horizon Prize on reducing maternal and new-born morbidity and
mortality - the Birth Day Prize
A novel solution is expected to improve the outcome of facility-
based deliveries, which might be of a clinical, technological or
managerial nature, or a combination of these. Any solution must
take full account of relevant social factors and have the potential
of scaling up rapidly.
Developed by European Commission and Bill & Melinda Gates
Foundation
Deadline: Second quarter of 2017
12. Horizon 2020 Advisory Group Report
Calls 2018-2020
Vertical themes
1. Personalised Medicine
2. Rare Diseases
3. Infectious Diseases
4. Non-communicable Diseases
5. Paediatrics
6. Public Health and prevention including migration
7. Active and healthy ageing
13. Horizon 2020 Scoping paper (draft)
Calls 2018-2020
4 priorities
1.Better health and care, economic growth and sustainable health systems
• Personalised Medicine
• Innovative health and care industry
• Improving global health
• Sustainable and evidence-based health and care systems
• Innovative health and care delivery services – integration of care
2. Decoding the role of the overall environment for health and well-being
• The human exposome
• Global changes and health (climate change, agri-food, migration)
3. Digital transformation in Health and care
• ehealth and mhealth
• ICT for Active and healthy ageing
4. Trusted Big Data solutions and Cybersecurity for Health and Care
• Trusted Big Data solutions for health and care
• Cybersecurity for health and care
15. Ref 2015 2016 2017 2018 2019 2020
Focus Area 1
Investigator-led projects (new) 1.1.1
HRB/MRCG Joint Funding Scheme 1.1.2
HRB/SFI Wellcome Biomedical Partnership 1.2.3 Rolling calls
US Ireland R&D Partnership Awards 1.2.2 Rolling calls
EU awards (e.g. JPIs / CSAs / ERA-Nets) 1.2.1 Rolling calls
Focus Area 2
Definitive Interventions & Feasibility Awards
(new) 2.1.1
Clinical Trial Networks 2.1.2
Focus Area 3
Applied Partnership Awards (new) 3.1.1
RCQPS (Collaboration in Quality & Patient Safety) 3.1.2
CICER (NCEC/HRB Clinical Effectiveness Hub) 3.3.2
Implementation Research (In development) 3.1 To be determined
Knowledge dissemination 3.1.3
Enabler A
PhD training in patient oriented research (new) A.1.1 New call under consideration
Postdoctoral awards A.2.1
Emerging Investigators (new) A.2.4
Senior Investigators A.3.1
Summer Scholarships A.4.2
Cancer nursing project development grant A.4.1
Short training courses (e.g. NCI Cancer Prev. F’ship) A.4.1 Ongoing
Enabler B
PPI (new) B.2.1 New call under consideration
Biobanking support (new) B.4.2
OPEN CALLS – INDICATIVE SCHEDULE 2016-2020